OTC · Financial Statements
4DMedical Limited (FDMDF) Financial Statements
$2.53
OTC: FDMDF
Market Cap $1.52B
Overview Financials Dividend
4DMedical Limited most recently reported annual revenue of $6.0M, a net loss of $30.0M. Revenue grew at an average annual rate of 43.1% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025
Revenue $0 $1.0M $1.0M $3.0M $6.0M Operating Profit $-14.0M $-22.0M $-31.0M $-47.0M $-29.0M Net Profit $-21.0M $-25.0M $-31.0M $-36.0M $-30.0M EPS $-0.08 $-0.08 $-0.10 $-0.10 $-0.14 Op Margin -6311.2% -2105.8% -4265.8% -1528.4% -499.2%
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025
Total Assets $93.0M $74.0M $93.0M $120.0M $95.0M Total Liabilities $9.0M $15.0M $21.0M $49.0M $31.0M Cash $81.0M $51.0M $70.0M $31.0M $7.0M Borrowings $2.0M $6.0M $5.0M $5.0M $4.0M
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025
Operating Cash Flow $-15.0M $-25.0M $-23.0M $-31.0M $-34.0M Investing Cash Flow $-1.0M $-7.0M $-4.0M $-40.0M $-2.0M Financing Cash Flow $-8.0M $-1.0M $0 $-2.0M $13.0M Net Cash Flow $72.0M $-30.0M $18.0M $-39.0M $-24.0M Free Cash Flow $-15.0M $-28.0M $-24.0M $-31.0M $-35.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.01 EV / EBITDA -65.54 FCF Yield -2.31% Quick Ratio 6.48 Interest Coverage -39.80 Return 1Y — Return 3Y — Return 5Y —
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer .